Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 54

    1.

    Increased Apolipoprotein AI Production Rate and Redistribution of High-Density Lipoprotein Size Induced by Estrogen plus Progestin as Oral Contraceptive.

    Duvillard L, Dautin G, Florentin E, Jeannin A, Pais de Barros JP, Lagrost L, Petit JM, Gambert P, Vergès B.

    J Clin Endocrinol Metab. 2009 Oct 26. [Epub ahead of print]PMID: 19858317 [PubMed - as supplied by publisher]Related articles

    2.

    A cholesterol-rich diet improves resistance to ischemic insult in mouse hearts but suppresses the beneficial effect of post-conditioning.

    Lauzier B, Delemasure S, Pesant M, Collin B, Duvillard L, Vergely C, Connat JL, Rochette L.

    J Heart Lung Transplant. 2009 Aug;28(8):821-6.PMID: 19632579 [PubMed - indexed for MEDLINE]Related articles

    3.

    Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients.

    Petit JM, Guiu B, Terriat B, Loffroy R, Robin I, Petit V, Bouillet B, Brindisi MC, Duvillard L, Hillon P, Cercueil JP, Verges B.

    J Clin Endocrinol Metab. 2009 Oct;94(10):4103-6. Epub 2009 Jul 7.PMID: 19584186 [PubMed - indexed for MEDLINE]Related articles

    4.

    Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerations.

    Debin R, Lauzier B, Sicard P, Delemasure S, Amoureux S, Duvillard L, Vergely C, Cottin Y, Rochette L.

    Fundam Clin Pharmacol. 2009 Feb;23(1):59-67.PMID: 19267771 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

    Vergès B, Florentin E, Baillot-Rudoni S, Petit JM, Brindisi MC, Pais de Barros JP, Lagrost L, Gambert P, Duvillard L.

    J Lipid Res. 2009 Jun;50(6):1209-15. Epub 2009 Jan 22.PMID: 19168444 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.

    Vergès B, Florentin E, Baillot-Rudoni S, Monier S, Petit JM, Rageot D, Gambert P, Duvillard L.

    Diabetologia. 2008 Aug;51(8):1382-90. Epub 2008 Jun 5.PMID: 18535816 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of various osmolarity on human red blood cells in terms of potassium efflux and hemolysis induced by free radicals.

    Lahet JJ, Lenfant F, Lecordier J, Bureau A, Duvillard L, Chaillot B, Freysz M.

    Biomed Pharmacother. 2008 Dec;62(10):697-700. Epub 2008 Mar 26.PMID: 18411008 [PubMed - indexed for MEDLINE]Related articles

    8.

    Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats.

    Sicard P, Delemasure S, Korandji C, Segueira-Le Grand A, Lauzier B, Guilland JC, Duvillard L, Zeller M, Cottin Y, Vergely C, Rochette L.

    Free Radic Res. 2008 Mar;42(3):226-36.PMID: 18344117 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.

    Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, Beer JC, Duvillard L, Lagrost AC, Moreau D, Gambert P, Cottin Y, Rochette L.

    Arterioscler Thromb Vasc Biol. 2008 May;28(5):954-60. Epub 2008 Feb 14.PMID: 18276906 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias.

    Duvillard L, Caslake MJ, Petit JM, Vergès B, Gambert P, Packard CJ.

    Atherosclerosis. 2008 Jul;199(1):27-33. Epub 2008 Jan 4.PMID: 18177876 [PubMed - indexed for MEDLINE]Related articles

    11.

    HDL particles from type 1 diabetic patients are unable to reverse the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation.

    Perségol L, Foissac M, Lagrost L, Athias A, Gambert P, Vergès B, Duvillard L.

    Diabetologia. 2007 Nov;50(11):2384-7. Epub 2007 Sep 12.PMID: 17846744 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load.

    Petit JM, Minello A, Duvillard L, Jooste V, Monier S, Texier V, Bour JB, Poussier A, Gambert P, Verges B, Hillon P.

    Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E416-20. Epub 2007 May 1.PMID: 17473053 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C.

    Petit JM, Jooste V, Duvillard L, Minello A, Texier V, Galland F, Gambert P, Verges B, Hillon P.

    Dig Dis Sci. 2007 Dec;52(12):3431-4. Epub 2007 Apr 11.PMID: 17436096 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate.

    Meyer BJ, Duvillard L, Owen A, Packard CJ, Caslake MJ.

    Atherosclerosis. 2007 Dec;195(2):e28-34. Epub 2007 Mar 6.PMID: 17336988 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

    Perségol L, Vergès B, Gambert P, Duvillard L.

    J Lipid Res. 2007 Jun;48(6):1396-401. Epub 2007 Feb 28.PMID: 17329618 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients.

    Galland F, Duvillard L, Petit JM, Lagrost L, Vaillant G, Brun JM, Gambert P, Vergès B.

    Diabetes Metab. 2006 Dec;32(6):625-31.PMID: 17296517 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.

    Duvillard L, Florentin E, Baillot-Rudoni S, Lalanne-Mistrich ML, Brun-Pacaud A, Petit JM, Brun JM, Gambert P, Vergès B.

    Atherosclerosis. 2007 Oct;194(2):342-7. Epub 2006 Dec 4.PMID: 17141785 [PubMed - indexed for MEDLINE]Related articles

    18.

    Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.

    Korandji C, Zeller M, Guilland JC, Vergely C, Sicard P, Duvillard L, Gambert P, Moreau D, Cottin Y, Rochette L.

    Clin Biochem. 2007 Jan;40(1-2):66-72. Epub 2006 Aug 30.PMID: 17020756 [PubMed - indexed for MEDLINE]Related articles

    19.

    The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane ultrafiltration coefficient.

    Dautin G, Boudjeltia S, Soltani Z, Gambert P, Duvillard L.

    Clin Chim Acta. 2007 Feb;376(1-2):237-9. Epub 2006 Aug 11.PMID: 16979612 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model.

    Collin B, Busseuil D, Zeller M, Perrin C, Barthez O, Duvillard L, Vergely C, Bardou M, Dumas M, Cottin Y, Rochette L.

    Mol Cell Biochem. 2007 Jan;294(1-2):225-35. Epub 2006 Jul 27.PMID: 16871360 [PubMed - indexed for MEDLINE]Related articles

    21.

    Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy.

    Duong M, Petit JM, Martha B, Galland F, Piroth L, Walldner A, Grappin M, Buisson M, Duvillard L, Chavanet P, Portier H.

    HIV Clin Trials. 2006 Mar-Apr;7(2):41-7.PMID: 16798618 [PubMed - indexed for MEDLINE]Related articles

    22.

    Plasma resistin concentration, and steatosis and insulin sensitivity in hepatitis C virus-infected patients.

    Petit JM, Minello A, Brisard C, Galland F, Duvillard L, Verges B, Hillon P.

    J Gastroenterol Hepatol. 2006 Mar;21(3):624. No abstract available. PMID: 16638116 [PubMed - indexed for MEDLINE]Related articles

    23.

    Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries.

    Collin B, Busseuil D, Korandji C, Zeller M, Cottin Y, Duvillard L, Rioufol G, Pitois-Merli I, Rochette L.

    J Cardiovasc Pharmacol. 2006 Mar;47(3):428-36.PMID: 16633086 [PubMed - indexed for MEDLINE]Related articles

    24.

    Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation.

    Perségol L, Vergès B, Foissac M, Gambert P, Duvillard L.

    Diabetologia. 2006 Jun;49(6):1380-6. Epub 2006 Apr 5.PMID: 16596357 [PubMed - indexed for MEDLINE]Related articles

    25.

    Adiponectin is an important determinant of apoA-I catabolism.

    Vergès B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P.

    Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1364-9. Epub 2006 Mar 30.PMID: 16574896 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients.

    Petit JM, Masson D, Minello A, Duvillard L, Galland F, Verges B, Gambert P, Hillon P.

    Mol Genet Metab. 2006 Jun;88(2):196-8. Epub 2006 Feb 2.PMID: 16458034 [PubMed - indexed for MEDLINE]Related articles

    27.

    Evaluation of the VITROS chemistry products dHDL slides for direct measurement of high density lipoprotein cholesterol.

    Duvillard L, Gambert P.

    Clin Chim Acta. 2006 Apr;366(1-2):130-6. Epub 2006 Jan 17.PMID: 16413009 [PubMed - indexed for MEDLINE]Related articles

    28.

    [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats]

    Sicard P, Lauzier B, Oudot A, Busseuil D, Collin B, Duvillard L, Moreau D, Vergely C, Rochette L.

    Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):804-8. French. PMID: 16220751 [PubMed - indexed for MEDLINE]Related articles

    29.

    Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.

    Faivre L, Saugier-Veber P, Pais de Barros JP, Verges B, Couret B, Lorcerie B, Thauvin C, Charbonnier F, Huet F, Gambert P, Frebourg T, Duvillard L.

    Eur J Hum Genet. 2005 Nov;13(11):1186-91.PMID: 16094309 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.

    Duvillard L, Florentin E, Baillot-Rudoni S, Lalanne-Mistrich ML, Brun-Pacaud A, Petit JM, Brun JM, Gambert P, Vergès B.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5761-4. Epub 2005 Aug 9.PMID: 16091481 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.

    Duvillard L, Florentin E, Lalanne-Mistrich ML, Petit JM, Baillot-Rudoni S, Brun-Pacaud A, Brun JM, Gambert P, Vergès B.

    Diabetologia. 2005 Jul;48(7):1366-72. Epub 2005 May 26.PMID: 15918022 [PubMed - indexed for MEDLINE]Related articles

    32.

    Direct, pleiotropic protective effect of cyclosporin A against simulated ischemia-induced injury in isolated cardiomyocytes.

    Bès S, Vandroux D, Tissier C, Devillard L, Brochot A, Tatou E, Duvillard L, Rochette L, Athias P.

    Eur J Pharmacol. 2005 Mar 28;511(2-3):109-20.PMID: 15792778 [PubMed - indexed for MEDLINE]Related articles

    33.

    Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients.

    Petit JM, Minello A, Jooste V, Bour JB, Galland F, Duvillard L, Verges B, Olsson NO, Gambert P, Hillon P.

    J Clin Endocrinol Metab. 2005 Apr;90(4):2240-3. Epub 2005 Jan 11.PMID: 15644404 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.

    Petit JM, Duong M, Masson D, Buisson M, Duvillard L, Bour JB, Brindisi MC, Galland F, Guiguet M, Gambert P, Portier H, Vergès B.

    Eur J Clin Invest. 2004 Aug;34(8):569-75.PMID: 15305892 [PubMed - indexed for MEDLINE]Related articles

    35.

    Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicity.

    Polycarpe E, Arnould L, Schmitt E, Duvillard L, Ferrant E, Isambert N, Duvillard C, Beltramo JL, Chevet D, Chauffert B.

    Int J Cancer. 2004 Aug 10;111(1):131-7.PMID: 15185354 [PubMed - indexed for MEDLINE]Related articles

    36.

    [Flow cytometric study of low density lipoprotein receptors: biological and clinical interest]

    Duvillard L, Gambert P, Lizard G.

    Ann Biol Clin (Paris). 2004 Jan-Feb;62(1):87-91. French. PMID: 15047497 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    [Microspheres, nanospheres and flow cytometry: from cellular to molecular analysis]

    Lizard G, Monier S, Prunet C, Duvillard L, Gambert P.

    Ann Biol Clin (Paris). 2004 Jan-Feb;62(1):47-52. Review. French. PMID: 15047490 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    [Microbeads, nanobeads and cytometry: applications to the analysis and purification of cells and biomolecules]

    Lizard G, Duvillard L, Wedemeyer N, Muller C, Ghiringhelli F, Cesbron A, Poncelet P, Gallet F, Kahn E, Gambert P, Göhde W.

    Pathol Biol (Paris). 2003 Sep;51(7):418-27. French. PMID: 12948764 [PubMed - indexed for MEDLINE]Related articles

    39.

    Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study.

    Petit JM, Duong M, Florentin E, Duvillard L, Chavanet P, Brun JM, Portier H, Gambert P, Verges B.

    J Lipid Res. 2003 Sep;44(9):1692-7. Epub 2003 Jun 16.PMID: 12869587 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

    Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

    Am J Gastroenterol. 2003 May;98(5):1150-4.PMID: 12809841 [PubMed - indexed for MEDLINE]Related articles

    41.

    Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy.

    Duvillard L, Florentin E, Lizard G, Petit JM, Galland F, Monier S, Gambert P, Vergès B.

    Diabetes Care. 2003 May;26(5):1540-4.PMID: 12716819 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.

    Pont F, Duvillard L, Florentin E, Gambert P, Vergès B.

    Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1726-32.PMID: 12377756 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study.

    Pont F, Duvillard L, Florentin E, Gambert P, Vergès B.

    Int J Obes Relat Metab Disord. 2002 Sep;26(9):1151-8.PMID: 12187390 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy.

    Petit JM, Duong M, Duvillard L, Florentin E, Portier H, Lizard G, Brun JM, Gambert P, Verges B.

    Eur J Clin Invest. 2002 May;32(5):354-9.PMID: 12027876 [PubMed - indexed for MEDLINE]Related articles

    45.

    Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?

    Pruneta V, Autran D, Ponsin G, Marcais C, Duvillard L, Verges B, Berthezene F, Moulin P.

    J Clin Endocrinol Metab. 2001 Feb;86(2):797-803.PMID: 11158049 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.

    Petit JM, Duong M, Duvillard L, Piroth L, Grappin M, Verges B, Chavanet P, Brun JM, Portier H.

    Horm Metab Res. 2000 Sep;32(9):367-72.PMID: 11014386 [PubMed - indexed for MEDLINE]Related articles

    47.

    Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

    Duvillard L, Pont F, Florentin E, Gambert P, Vergès B.

    Atherosclerosis. 2000 Sep;152(1):229-37.PMID: 10996359 [PubMed - indexed for MEDLINE]Related articles

    48.

    Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.

    Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Vergès B.

    Eur J Clin Invest. 2000 Aug;30(8):685-94.PMID: 10964160 [PubMed - indexed for MEDLINE]Related articles

    49.

    Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus.

    Duvillard L, Pont F, Florentin E, Gambert P, Vergès B.

    Diabetologia. 2000 Jan;43(1):27-35.PMID: 10663213 [PubMed - indexed for MEDLINE]Related articles

    50.

    [Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay]

    Egloff M, Léglise D, Duvillard L, Steinmetz J, Boyer MJ, Ruelland A, Agher R, Beucler I.

    Ann Biol Clin (Paris). 1999 Sep-Oct;57(5):561-72. French. Erratum in: Ann Biol Clin (Paris) 2000 Jul-Aug;58(4):511. PMID: 10518058 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...